Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Landi

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Contraception, Fertilite, Sexualite (1992)|February 17, 2000
[Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients]J Saurel, M Rabreau, M Landi, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 4, 2017
Occipital White Matter Tracts in Human and MacaqueHiromasa Takemura, Franco Pestilli, Kevin S Weiner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 16, 2018
Nasal cytology: Methodology with application to clinical practice and researchE Heffler, M Landi, C Caruso, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Marine Biotechnology (New York, N.Y.)|February 14, 2008
DNA microarrays for identifying fishesM Kochzius, M Nölte, H Weber, et al.
Neuropeptides|December 31, 1997
Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonistX Emonds-Alt, C Advenier, C Cognon, et al.
ESMO Gastrointestinal Oncology|March 27, 2026
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER studyG Trovato, M Carullo, A Nicastro, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Contraception, Fertilite, Sexualite (1992)|February 17, 2000
[Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients]J Saurel, M Rabreau, M Landi, et al.
Cerebral Cortex (New York, N.Y. : 1991)|April 4, 2017
Occipital White Matter Tracts in Human and MacaqueHiromasa Takemura, Franco Pestilli, Kevin S Weiner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 16, 2018
Nasal cytology: Methodology with application to clinical practice and researchE Heffler, M Landi, C Caruso, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Marine Biotechnology (New York, N.Y.)|February 14, 2008
DNA microarrays for identifying fishesM Kochzius, M Nölte, H Weber, et al.
Neuropeptides|December 31, 1997
Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonistX Emonds-Alt, C Advenier, C Cognon, et al.
ESMO Gastrointestinal Oncology|March 27, 2026
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER studyG Trovato, M Carullo, A Nicastro, et al.
Pageof 9